Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · Real-Time Price · USD
4.280
-0.130 (-2.95%)
Mar 5, 2026, 4:00 PM EST - Market closed
Sensus Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 27.48 | 41.81 | 24.41 | 44.53 | 27.04 | Upgrade
|
| Revenue Growth (YoY) | -34.27% | 71.30% | -45.20% | 64.68% | 182.36% | Upgrade
|
| Cost of Revenue | 15.62 | 17.38 | 10.35 | 14.9 | 10.05 | Upgrade
|
| Gross Profit | 11.87 | 24.43 | 14.06 | 29.63 | 16.99 | Upgrade
|
| Selling, General & Admin | 14.4 | 12.13 | 10.76 | 11.34 | 9.43 | Upgrade
|
| Research & Development | 7.78 | 4.22 | 3.68 | 3.46 | 3.44 | Upgrade
|
| Operating Expenses | 22.17 | 16.34 | 14.44 | 14.8 | 12.87 | Upgrade
|
| Operating Income | -10.31 | 8.09 | -0.38 | 14.83 | 4.12 | Upgrade
|
| Interest Expense | - | - | - | - | -0 | Upgrade
|
| Interest & Investment Income | 0.68 | 0.93 | 0.99 | 0.38 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -9.62 | 9.02 | 0.61 | 15.21 | 4.12 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.04 | 12.78 | -0 | Upgrade
|
| Pretax Income | -9.62 | 9.02 | 0.65 | 27.99 | 4.12 | Upgrade
|
| Income Tax Expense | -1.91 | 2.38 | 0.17 | 3.75 | - | Upgrade
|
| Net Income | -7.72 | 6.65 | 0.49 | 24.24 | 4.12 | Upgrade
|
| Net Income to Common | -7.72 | 6.65 | 0.49 | 24.24 | 4.12 | Upgrade
|
| Net Income Growth | - | 1270.51% | -98.00% | 488.59% | - | Upgrade
|
| Shares Outstanding (Basic) | 16 | 16 | 16 | 16 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 16 | 16 | 16 | 17 | 17 | Upgrade
|
| Shares Change (YoY) | -0.20% | 0.57% | -2.12% | 0.70% | 0.42% | Upgrade
|
| EPS (Basic) | -0.47 | 0.41 | 0.03 | 1.47 | 0.25 | Upgrade
|
| EPS (Diluted) | -0.47 | 0.41 | 0.03 | 1.46 | 0.25 | Upgrade
|
| EPS Growth | - | 1266.06% | -97.96% | 484.00% | - | Upgrade
|
| Free Cash Flow | - | -1.11 | -2.37 | -1.57 | -0.41 | Upgrade
|
| Free Cash Flow Per Share | - | -0.07 | -0.15 | -0.10 | -0.03 | Upgrade
|
| Gross Margin | 43.18% | 58.44% | 57.61% | 66.53% | 62.82% | Upgrade
|
| Operating Margin | -37.51% | 19.35% | -1.57% | 33.30% | 15.24% | Upgrade
|
| Profit Margin | -28.09% | 15.90% | 1.99% | 54.44% | 15.23% | Upgrade
|
| Free Cash Flow Margin | - | -2.65% | -9.73% | -3.53% | -1.53% | Upgrade
|
| EBITDA | -9.93 | 8.33 | -0.11 | 15.15 | 4.73 | Upgrade
|
| EBITDA Margin | -36.13% | 19.92% | -0.44% | 34.01% | 17.50% | Upgrade
|
| D&A For EBITDA | 0.38 | 0.24 | 0.28 | 0.32 | 0.61 | Upgrade
|
| EBIT | -10.31 | 8.09 | -0.38 | 14.83 | 4.12 | Upgrade
|
| EBIT Margin | -37.50% | 19.35% | -1.57% | 33.30% | 15.24% | Upgrade
|
| Effective Tax Rate | - | 26.32% | 25.61% | 13.38% | - | Upgrade
|
| Advertising Expenses | - | 1.2 | 1.2 | 0.9 | 0.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.